Long-term results of Nivolumab + Cabozantinib in RCC

Published Date: 08 Mar 2023

The combination of first-line nivolumab and cabozantinib continues to outperform sunitinib in the treatment of patients with advanced renal cell carcinoma (RCC).

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects

2.

Drug-chemo combo increases cancer treatment efficacy

3.

MRI can save rectal cancer patients from surgery, study suggests

4.

Study sets benchmark for treatment of advanced cervical cancer

5.

Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot